FDA inspection
Sharp Corporation d/b/a Sharp Packaging Solutions: FDA inspection ending May 24, 2002
FDA inspection 218110 · Voluntary Action Indicated (VAI) · Conshohocken, PA
Key facts
| Inspection ID | 218110 |
|---|---|
| Firm | Sharp Corporation d/b/a Sharp Packaging Solutions |
| FEI number | 2518332 |
| Address | 23 Carland Rd |
| City | Conshohocken |
| State | PA |
| ZIP | 19428-1064 |
| Fiscal year | 2002 |
| Inspection end date | May 24, 2002 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation|Monit of Marketed Animal Drug,Feed &Dev|New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data